1. |
黄雪珊, 陈道中, 廖崇先, 等. 人工机械瓣膜置换术 50 例抗凝治疗随访. 福建医科大学学报, 2003, 37(2): 224-226.
|
2. |
张小飞, 肖亦敏, 程云阁, 等. 心脏机械瓣膜置换术后华法林低强度抗凝治疗的临床分析. 中国胸心血管外科临床杂志, 2014, 21(2): 270-271.
|
3. |
朱志成, 李丹, 王天策, 等. 东北人群人工机械瓣膜置换术后低强度抗凝治疗的单中心研究. 中国胸心血管外科临床杂志, 2014, 21(2): 160-163.
|
4. |
The International Warfarin Pharmacogenetics Consortium. Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med, 2009, 360(8): 753-764.
|
5. |
Kimmel SE, French B, Kasner SE, et al. A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med, 2013, 369(24): 2283-2293.
|
6. |
Pirmohamed M, Burnside G, Eriksson N, et al. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med, 2013, 369(24): 2294-2303.
|
7. |
Furie B. Do pharmacogenetics have a role in the dosing of vitamin K antagonists? N Engl J Med, 2013, 369(24): 2345-2346.
|
8. |
Elewal H, Jalali F, Khudair N, et al. Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar. J Eval Clin Pract, 2016, 22(3): 433-438.
|
9. |
Entezari-Maleki T, Dousti S, Hamishehkar H, et al. A systematic review on comparing 2 common models for management of warfarin therapy: pharmacist-led service versus usual medical care. J Clin Pharmacol, 2016, 56(1): 24-38.
|
10. |
Bishop L, Young S, Twells L, et al. Patients’ and physicians’ satisfaction with a pharmacist managed anticoagulation program in a family medicine clinic. BMC Res Notes, 2015, 8: 233.
|
11. |
Young S, Bishop L, Twells L, et al. Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic. BMC Family Practice, 2011, 12: 88.
|
12. |
Hicho MD, Rybarczyk A, Boros M. Interventions unrelated to anticoagulation in a pharmacist-managed anticoagulation clinic. Am J Health-Syst Pharm, 2016, 73(3): S80-S87.
|
13. |
中华医学会心血管病学分会、中国老年学学会心脑血管病专业委员会. 华法林抗凝治疗的中国专家共识. 中华内科杂志, 2013, 52(1): 76-82.
|
14. |
Lane MA, Zeringue A, McDonald JR. Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans. Am J Med, 2014, 127(7): 657-663.
|
15. |
Arnold LM, Nissen LR, Ng TM. Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction. Pharmacotherapy, 2005, 25(6): 904-907.
|
16. |
Yamamoto H, Habu Y, Yano I, et al. Comparison of the effects of azole antifungal agents on the anticoagulant activity of warfarin. Biol Pharm Bull, 2014, 37(12): 1990-1993.
|
17. |
Danie LM, Barreto JN, Kuth JC, et al. Failure mode and effects analysis to reduce risk of anticoagulation levels above the target range during concurrent antimicrobial therapy. Am J Health-Syst Pharm, 2015, 72(14): 1195-1203.
|
18. |
McEwen BJ. The influence of herbal medicine on platelet function and coagulation: a narrative review. Semin Thromb Hemost, 2015, 41(3): 300-314.
|
19. |
Tsai HH, Lin HW, Lu YH, et al. A review of potential harmful interactions between anticoagulant/antiplatelet agents and chinese herbal medicines. Plos One, 2013, 8(5): e64255.
|
20. |
Chua YT, Ang XL, Zhong XM, et al. Interaction between warfarin and Chinese herbal medicines. Singapore Med J, 2015, 56(1): 11-18.
|